AZD3965 |
AZD3965 : Inhibitor of SLC16A1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| SLC16A1 |
|
|
Inhibitor
up to 100 nM
Selectivity
In Vitro Selectivity Assessment
SLC16A7
Gene ID: O60669
Organism: Homo sapiens
Family: Monocarboxylate porter (TC 2.A.1.13) family
Potency: Ki - 20 nM
Selectivity Assessment Description:
No inhibition of lactate transport mediated by MCT3 or MCT4 w in the MCT1, MCT2, MCT3 and MCT4 null ...
Potency Cellular
In Vitro
SLC16A1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.18632/oncotarget.18215
In Vivo Validations
Mouse
Dose: 10 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
2.91 h
Systemic clearance:
56.1 ml/h
Cmax:
4.02 ug/ml
Area Under the Curve::
4.94 ug*h/ml
Volume of Distribution at Steady-State:
44.2 ml/Kg
DOI Reference: 10.1007/s11095-019-2735-z
Dose: 100 mg/Kg
Route of delivery:
Oral
Plasma half life:
4.46 h
Systemic clearance:
26.6 ml/h
Cmax:
30.3 ug/ml
Area Under the Curve::
71.4 ug*h/ml
DOI Reference: 10.1007/s11095-019-2735-z
Chemical Information
| Molecular Formula | C21H24F3N5O5S |
| SMILEs | Cc1[nH]nc(C(F)(F)F)c1Cc1sc2c(c1C(=O)N1C[C@](C)(O)CO1)c(=O)n(C)c(=O)n2C(C)C |
| InChI | InChI=1S/C21H24F3N5O5S/c1-9(2)29-18-14(16(30)27(5)19(29)32)13(17(31)28-7-20(4,33)8-34-28)12(35-18)6-11-10(3)25-26-15(11)21(22,23)24/h9,33H,6-8H2,1-5H3,(H,25,26)/t20-/m0/s1 |
| Molecular weight | 515.15 Da |
| AlogP | 0.0 |
| HBond acceptors | 10 |
| HBond donors | 2 |
| Atoms | 59 |